In 2015, Xu et al. performed an shRNA loss-of-function screen in cell lines derived from BRCA1−/−p53−/− mouse mammary tumors to identify BRCA1-independent mechanisms leading to restored HR (15). The gene discussed is BRCA1; the disease is breast cancer.